About HNL Genomics (CTGT)

HNL Genomics (CTGT) a division of HNL Lab Medicine, is an international provider specializing in molecular diagnostic testing services for inherited genetic disorders.

HNL Genomics (CTGT) offers a comprehensive test menu and serves hundreds of leading healthcare providers and institutions from the US and around the world.

The company uses its proprietary analytic methods, mutation database, and technology to provide more than 3,300 unique tests covering over 1,000 genes. Its efficient systems and team of experts enable HNL Genomics (CTGT) to provide clear and actionable results, rapidly develop and deploy new tests, and offer superior customer service with best-in-industry, turn-around times.

Why Use HNL Genomics (CTGT)

Our vast experience and long term dedication to providing high quality molecular diagnostic tests distinguish us from other laboratories.
  • HNL Genomics' (CTGT) development and technology is an internationally-recognized leader in the molecular biology of connective tissue disorders. HNL Genomics (CTGT) remains committed to translating unique expertise into clinical and technical value for the company’s clients.
  • HNL Genomics (CTGT) has performed thousands of genetic tests and has compiled comprehensive mutation databases for many genes.  Our extensive experience and superior data sets enable us to provide a more accurate analysis of test results than other diagnostic laboratories.
  • HNL Genomics (CTGT) remains at the forefront of new testing methodologies and technologies, rapidly implementing those that are proven to be reliable, accurate and superior or complementary to existing technology.
  • HNL Genomics (CTGT) maintains focused on providing the highest standards for laboratory quality and accuracy.

Superior Service

  • HNL Genomics' (CTGT) experts are available by email and telephone to provide timely consultation with physicians and genetic counselors.
  • The company achieves the fastest turn-around times available for molecular diagnostics of inherited genetic disorders.
  • Our professional administrative staff is always ready to help with billing related questions.
  • HNL Genomics (CTGT) welcomes your suggestions regarding the development of additional tests and panels.
  • HNL Genomics (CTGT) also welcomes inquiries from other laboratories seeking excellent reference services.

Our Mission

HNL Genomics (CTGT) is dedicated to helping physicians accurately diagnose inherited genetic disorders by offering highly sensitive tests for a broad range of inherited genetic disorders while providing superior customer service in all our activities.

About HNL Lab Medicine

HNL Lab Medicine is a leading, full-service medical laboratory providing testing and related services to physician offices, hospitals, long-term care facilities, employers, and industrial accounts. 

Each year, HNL Lab Medicine generates more than 60 million clinical and anatomic pathology results for approximately 3 million patients and 12,000 healthcare providers. 

HNL Lab Medicine operates more than 50 patient service centers in Pennsylvania. Its staff of over 1,000 includes 35 board-certified pathologists and scientific directors and more than 400 certified lab scientists and phlebotomists working together to provide high-quality, advanced diagnostic testing. For more information, visit HNL.com.

The American Medical Association (AMA) Current Procedural Terminology (CPT) codes published by HNL Lab Medicine are guidelines and are intended for informational purposes only. CPT coding is the exclusive responsibility of the billing entity. HNL Lab Medicine strongly recommends confirmation of CPT codes with third-party payors and/or the AMA. We assume no responsibility for billing errors due to reliance upon CPT codes provided by HNL Lab Medicine.


October 28, 2022

Non-Hodgkin Lymphoma FISH Panel Now Available

B-cell lymphoma is a large group of heterogenous disorders and comprises a majority of non-Hodgkin lymphomas.
Read More
October 20, 2022

Genetic testing for Familial Transthyretin Amyloidosis (TTR) NOW AVAILABLE In-House

Hereditary amyloidosis is a life-threatening disorder that can lead to peripheral neuropathy and heart failure.
Read More
August 08, 2022

Familial hypercholesterolemia (FH)

Familial hypercholesterolemia (FH) is a genetic disorder that increases the likelihood of having coronary heart disease at a younger age. Learn about how to determine if you have hypercholesterolemia and what actions you can take to create better outcomes!

Read More
April 11, 2022

Genome Sequencing: A Vital Tool Used in Identifying and Tracking New COVID-19 Variants

Genome sequencing is reading or decoding the complete genetic information i.e. “Genome” of an organism that is encrypted in the form of a very long string called DNA made up of 4 letters, A, T, G, and C. The genome of an organism essentially determines their physical characteristics and ...
Read More
March 03, 2022

The Effect of Genetics on Individual Heart Health: Early Identification of FH Variations to Optimize Treatment

Test must be ordered by a Physician.

Familial hypercholesterolemia (FH) is a genetic disorder that is characterized by abnormally high blood levels of low-density lipoprotein (LDL) cholesterol, sometimes referred to as "bad cholesterol". This condition affects an estimated 1 in 250 people, and increases the likelihood of developing cardiovascular disease. In fact, FH is estimated to be the cause of 2-3% of heart attacks in individuals younger than age 60.

Read More